2014•IOSR Journal of Dental and Medical SciencesOpen access

Comparative study of efficacy of Enalapril and Enalapril with Losartan in the management of Heart Failure

Dr.Zaheda Bano

Open full text 1 citations

Abstract

Heart failure is one of the most common causes of death and disability encountered in clinical practice.Recently animal studies and clinical trials demonstrated additional benefits following the addition of an Angiotensin receptor blocker to existing Angiotensin converting enzyme inhibitor.It was a comparative randomized study performed on 100 patients admitted in cardiology Department, Government General Hospital, and Guntur.The study comprised of 6 weeks period for each patient .50patients were under Enalapril and 50 patients were under combination of Enalapril and Losartan.Before and after 6 weeks, Blood studie ,E.C.G ,Chest x ray ,2D echo were done .Patients were monitored for relief of symptoms ,change in blood pressure and adverse effects.Results were tabulated, unpaired students't' test was done and p values were calculated .Results were shown graphically also.The combination therapy improved the symptoms ,ejection fraction (P < 0.001 ) and increased serum potassium significantly.(P < 0.05) .So,the present study showed that combination therapy (Enalapril plus losartan) had better efficacy than Enalapril alone in the management of congestive cardiac failure.

Open-access reader

About this research paper

What this paper is about

Heart failure is one of the most common causes of death and disability encountered in clinical practice.Recently animal studies and clinical trials demonstrated additional benefits following the addition of an Angiotensin receptor blocker to existing Angiotensin converting enzyme inhibitor.It was a comparative randomized study performed on 100 patients admitted in cardiology Department, Government General Hospital, and Guntur.The study comprised of 6 weeks period for each patient .50patients were under Enalapril and 50 patients were under combination of Enalapril and Losartan.Before and after 6 weeks, Blood studie ,E.C.G ,Chest x ray ,2D echo were done .Patients were monitored for relief of symptoms ,change in blood pressure and adverse effects.Results were tabulated, unpaired students't' test was done and p values were calculated .Results were shown graphically also.The combination therapy improved the symptoms ,ejection fraction (P < 0.001 ) and increased serum potassium significantly.(P < 0.05) .So,the present study showed that combination therapy (Enalapril plus losartan) had better efficacy than Enalapril alone in the management of congestive cardiac failure.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Heart failure is one of the most common causes of death and disability encountered in clinical practice.Recently animal studies and clinical trials demonstrated additional benefits following the addition of an Angiotensin receptor blocker to existing Angiotensin converting enzyme inhibitor.It was a comparative randomized study performed on 100 patients admitted in cardiology Department, Government General Hospital, and Guntur.The study comprised of 6 weeks period for each patient .50patients were under Enalapril and 50 patients were under combination of Enalapril and Losartan.Before and after 6 weeks, Blood studie ,E.C.G ,Chest x ray ,2D echo were done .Patients were monitored for relief of symptoms ,change in blood pressure and adverse effects.Results were tabulated, unpaired students't' test was done and p values were calculated .Results were shown graphically also.The combination therapy improved the symptoms ,ejection fraction (P < 0.001 ) and increased serum potassium significantly.(P < 0.05) .So,the present study showed that combination therapy (Enalapril plus losartan) had better efficacy than Enalapril alone in the management of congestive cardiac failure.

Key concepts: Medicine, Enalapril, Losartan, Heart failure, Cardiology, Internal medicine, Pharmacology, Angiotensin-converting enzyme

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative study of efficacy of Enalapril and Enalapril with Losartan in the management of Heart Failure — Research Paper | ScholarLens